MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
NOVO.B.DK Novo Nordisk A/S Class B 77.1 ¤285,495 DK
RO.CH Roche Holding Ltd 58.8 ¤262,192 CH
ASML.NL ASML Holding NV 76.9 ¤252,343 NL
NOVN.CH Novartis AG 60.0 ¤210,118 CH
LIN Linde plc 51.3 ¤209,902 GB

Five Smallest Companies
Symbol Name Grade Market Cap Country
INDU.C.SE Industrivarden AB Class C 33.3 ¤14,312 SE
A5G.IE AIB Group plc 82.1 ¤14,524 IE
8TRA.DE TRATON SE 56.3 ¤14,932 DE
SGE.GB Sage Group plc 62.0 ¤15,132 GB
IAG.GB International Consolidated Airlines Grou 69.0 ¤15,677 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 76.9 32 NL
ACN Accenture Plc Class A 59.2 31 IE
DNB.NO DNB Bank ASA 72.9 28 NO
ALV.DE Allianz SE 50.1 27 DE
NOVO.B.DK Novo Nordisk A/S Class B 77.1 27 DK
ASSA.B.SE ASSA ABLOY AB Class B 55.8 26 SE
TEL TE Connectivity plc 55.0 25 IE
ETN Eaton Corp. Plc 59.8 24 IE
VOLV.B.SE Volvo AB Class B 63.6 24 SE
IFX.DE Infineon Technologies AG 51.6 23 DE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤60,630
Median Market Cap ¤37,188
Avg. 3 Mo. Dollar Vol. ¤184,290,981
Avg. 3 Mo. Trading Vol. 5,194,264
Last Rebalance Date 03/24/2025
Companies Replaced 35
Biggest Sector Increase Consumer Staples
Biggest Sector Decrease Energy

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 15.9
Forward P/E Ratio (12 Mo.) 14.2
Price/Book Ratio 2.5
Avg. Revenue Chg. - 3 Yr 34.7%
Avg. Op. Income Chg. - 3 Yr. 43.5%
Avg. EPS Growth - 3 Yr. 15.4%
Avg. EPS Growth - 1 Yr. 12.4%
Avg. Operating Margin 19.2%
Avg. LT Debt to Total Capital 45.7%
Avg. Return on Equity 17.4%
Dividend Yield 2.8%
Index Average Grade
Europe 100 Index 58.15
Country Breakdown
United Kingdom 18.0%
Sweden 14.0%
Ireland 11.0%
Switzerland 11.0%
Germany 10.0%
Spain 6.0%
Italy 6.0%
Netherlands 6.0%
France 6.0%
Denmark 4.0%
Finland 2.0%
Austria 2.0%
Norway 2.0%
Belgium 1.0%
Czech Republic 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE